Deep Track Capital, LP Nurix Therapeutics, Inc. Put Options Transaction History
Deep Track Capital, LP
- $2.82 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NRIX
# of Institutions
174Shares Held
79.4MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$59.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$38.7 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$34.2 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$33.7 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA3.73MShares$32.4 Million5.17% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $409M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...